A new Ap­ple Tree Part­ners biotech launch­es with $55M to make ‘pan-vari­ant’ an­tivi­rals 

Red Queen Ther­a­peu­tics is emerg­ing from stealth with $55 mil­lion from ven­ture cap­i­tal group Ap­ple Tree Part­ners, and plans to de­vel­op treat­ments for a swathe …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER